Education
About Us
Working with TipRanks
Follow Us
HeartFlow, Inc. (HTFL)
NASDAQ:HTFL
HTFL Stock Chart & Stats
$26.82
--
Market closed
$26.82
--
Day’s Range― - ―
52-Week Range$20.13 - $41.22
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.62M
Market Cap
$2.30B
Enterprise Value$2.26B
Total Cash (Recent Filing)$176.79M
Total Debt (Recent Filing)$22.05M
Price to Earnings (P/E)―
Beta2.45
Next Earnings
May 07, 2026EPS Estimate
-0.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.12
Shares Outstanding85,757,750
10 Day Avg. Volume1,859,055
30 Day Avg. Volume1,624,470
Financial Highlights & Ratios
PEG Ratio11.42
Price to Book (P/B)35.73
Price to Sales (P/S)61.03
P/FCF Ratio-181.94
Enterprise Value/Market Cap0.98
Enterprise Value/Revenue12.85
Enterprise Value/Gross Profit16.73
Enterprise Value/Ebitda-35.95
Forecast
1Y Price Target
$37.67Price Target Upside40.45% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)-0.59
Revenue Forecast (FY)$212.94M
Bulls Say, Bears Say
Bulls Say
Clinical Evidence And Competitive MoatExtensive published clinical evidence and a large proprietary library of coronary CT scans create a durable barrier to new competitors and support physician trust in the technology's clinical value.
Earnings And GuidanceAnalyst's recommendation reflects results that beat expectations while guidance appears conservative given an anticipated ramp in plaque analysis adoption, implying potential upside to revenue forecasts.
Reimbursement And CoverageMedicare reimbursement combined with expanding commercial payor wins and permanent coding for plaque analysis should broaden coverage and improve the economic case for clinicians to adopt the service.
Bears Say
Access And Physician Certification ConstraintsLimited access to cardiac CT in rural areas and many cardiologists not certified to read cardiac CT constrain the addressable market and slow broader utilization outside major centers.
Market Sentiment/AI OverhangGrouping with AI-related names has generated broad market selling pressure that can weigh on the stock despite regulatory hurdles and the company's established clinical track record.
Share Overhang And LockupExpiration of a lockup agreement increases the supply of tradable shares and can create a technical overhang that puts downward pressure on the stock.
HeartFlow, Inc. News
HTFL FAQ
What was HeartFlow, Inc.’s price range in the past 12 months?
HeartFlow, Inc. lowest stock price was $20.13 and its highest was $41.22 in the past 12 months.
What is HeartFlow, Inc.’s market cap?
HeartFlow, Inc.’s market cap is $2.30B.
When is HeartFlow, Inc.’s upcoming earnings report date?
HeartFlow, Inc.’s upcoming earnings report date is May 07, 2026 which is in 44 days.
How were HeartFlow, Inc.’s earnings last quarter?
HeartFlow, Inc. released its earnings results on Feb 12, 2026. The company reported -$0.12 earnings per share for the quarter, beating the consensus estimate of -$0.169 by $0.049.
Is HeartFlow, Inc. overvalued?
According to Wall Street analysts HeartFlow, Inc.’s price is currently Undervalued.
Does HeartFlow, Inc. pay dividends?
HeartFlow, Inc. does not currently pay dividends.
What is HeartFlow, Inc.’s EPS estimate?
HeartFlow, Inc.’s EPS estimate is -0.19.
How many shares outstanding does HeartFlow, Inc. have?
HeartFlow, Inc. has 85,757,750 shares outstanding.
What happened to HeartFlow, Inc.’s price movement after its last earnings report?
HeartFlow, Inc. reported an EPS of -$0.12 in its last earnings report, beating expectations of -$0.169. Following the earnings report the stock price went down -8.137%.
Which hedge fund is a major shareholder of HeartFlow, Inc.?
Currently, no hedge funds are holding shares in HTFL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HeartFlow, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$37.67 (40.45% Upside)
$37.67 (40.45% Upside)
Blogger Sentiment
Bullish
HTFL Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 249.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $56.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 17.9%
Last 30 Days ▼ 17.9%
News Sentiment
Bullish
Bullish news 75%
Bearish news 25%
Bearish news 25%
Company Description
HeartFlow, Inc.
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.
HTFL Earnings Call
Q3 2025
0:00 / 0:00
HTFL Stock 12 Month Forecast
Average Price Target
$37.67
▲(40.45% Upside)
Technical Analysis
Ownership Overview
33.50% Insiders
12.09% Mutual Funds
32.02% Other Institutional Investors
19.36% Public Companies and
Individual Investors